NKGNW
NKGen Biotech, Inc. Warrants
NKGNW
NKGNW
Delisted
NKGNW was delisted on the 4th of March, 2025.
32 hedge funds and large institutions have $1.52M invested in NKGen Biotech, Inc. Warrants in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
32
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$26.7K | |
| 2 | +$18.2K | |
| 3 | +$5.99K | |
| 4 |
SCM
Saba Capital Management
New York
|
+$5K |
Top Sellers
| 1 | -$76K | |
| 2 | -$7.24K | |
| 3 | -$7K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$5K |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$5K |